CORONAVIRUS/Taiwan's CDC to publish Medigen COVID-19 research in U.S. journal
02/02/2024 09:53 PM
A COVID-19 vaccine research from Taiwan-based Medigen Vaccine Biologics Corp., which found its locally-produced vaccine was as effective as the Moderna and Pfizer BioNTech vaccines, will be featured in a United States medical publication.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Weekly COVID-19 cases in Taiwan surge 78%, extend climb: CDCNearly 6,000 individuals sought medical treatment for COVID-19 last week, marking a 78 percent increase from the previous week and the fourth consecutive weekly rise in cases, the Centers for Disease Control (CDC) said Tuesday.05/07/2025 12:13 PM
- COVID-19 epidemic phase to pass mid-August: CDCAlthough Taiwan is still in a COVID-19 epidemic phase, it is expected to pass by mid-August, said the Centers for Disease Control (CDC) at a press conference in Taipei on Tuesday.07/30/2024 08:01 PM
- COVID-19, influenza outbreaks have peaked: CDCCOVID-19 and influenza cases in Taiwan have peaked, with the epidemic phases likely to pass by mid-August, the Centers for Disease Control (CDC) said Tuesday.07/16/2024 08:45 PM
Latest
- Business
U.S. dollar down in Taipei trading
05/19/2025 10:23 AM - Society
Taiwan headline news
05/19/2025 10:00 AM - Business
Taiwan shares open lower
05/19/2025 09:16 AM - Society
Two tourists injured in lightning strike on Keelung Islet
05/18/2025 10:33 PM - Society
Landslides disrupt rail traffic in Hualien
05/18/2025 09:10 PM